An interventional study of Combination of 30 Degree Head Up and Murottal Therapy and Standard Care (in control arm) in Stroke, sponsored by Universitas Muhammadiyah Surakarta. Not yet recruiting at 1 site in Indonesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-12.
Sponsored by Universitas Muhammadiyah Surakarta · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Stroke with a site in Indonesia — 7 open to participants now, 8 under way, none of them phase 3. Stroke · Indonesia.
Among the 13 studies in Stroke with a site in Indonesia, this one is the 3rd largest by planned enrollment of the 10 interventional ones that give a count, is one of 4 that started in 2026, is one of 7 with no phase, and was the 10th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →7 of the 13 studies in Stroke with a site in Indonesia are open now. Recruiting first, the newest first:
Universitas Padjadjaran · Sites in Indonesia
Ages 18+
Hasanuddin University · Sites in Indonesia
Kaohsiung Medical University · Sites in Indonesia
Ages 18–90
Universitas Padjadjaran · Sites in Indonesia
Ages 40–65
Universitas Padjadjaran · Sites in Indonesia
Ages 18–59
A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 1 · Phase 3 2
First in 2007; this study’s year is marked. 4 started in 2026.
This study's planned enrollment of 112 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 44 across the 10 interventional studies, 2,297 across the 3 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 13 have an industry lead sponsor. The 9 most frequent:
Universitas Muhammadiyah Surakarta is the lead sponsor of 11 studies on the registry; 4 are open to participants now.
Universitas Muhammadiyah Surakarta has 1 study filed under Stroke — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Stroke with a site in Indonesia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effects of a combination of a 30-degree head-up position and murottal therapy on physiological and symptom outcomes in stroke patients. The intervention is expected to influence blood pressure, pulse rate, respiratory rate, pain level, and the incidence of projectile vomiting. Stroke patients will receive standard care with the addition of the combined intervention. The results of this study may support non-pharmacological nursing interventions to improve patient comfort and clinical stability.
Stroke patients often experience physiological instability and discomfort, including changes in blood pressure, pulse rate, respiratory rate, pain, and nausea or vomiting. Non-pharmacological nursing interventions are needed to support patient comfort and clinical stability during acute care. Head-up positioning and murottal therapy are commonly used supportive interventions in nursing practice, but evidence regarding their combined effects remains limited.
This study aims to evaluate the effects of a combination of a 30-degree head-up position and murottal therapy on blood pressure, pulse rate, respiratory rate, pain degree, and projectile vomiting in stroke patients. The study involves stroke patients receiving standard medical and nursing care, with the addition of the combined intervention as part of supportive nursing management.
The head-up position will be applied at a 30-degree angle, while murottal therapy will be delivered through 30-minute audio recitation during for 3 days. Physiological parameters and symptom outcomes will be measured before and after the intervention according to the study protocol. The findings of this study are expected to contribute evidence for the use of simple, non-pharmacological nursing interventions to improve comfort and physiological responses in stroke patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria :
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive a combination of 30-degree head-up positioning and murottal therapy in addition to standard nursing care during the intervention period.
Other: Combination of 30 Degree Head Up and Murottal Therapy
Participants receive standard nursing care according to the hospital's clinical protocol without the addition of head-up positioning or murottal therapy.
Other: Standard Care (in control arm)
Participants in this group received a combination of two non-pharmacological interventions during the study period. First, participants were positioned with their heads elevated at a 30-degree angle while lying in bed to support physiological stability, including monitoring of blood pressure, pulse rate, respiratory rate, pain level, and projectile vomiting. Second, participants listened to Quranic recitation (murottal therapy) via audio recording in a quiet environment. Both interventions were administered simultaneously. Intervention sessions lasted 30 minutes for 3 days (a consistent duration and frequency for all participants in this group). Outcomes such as vital signs, pain level, and episodes of severe vomiting were monitored before and after the intervention period.
Participants in this arm receive standard nursing care according to the hospital protocol without additional head-up positioning or murottal therapy. Standard care includes routine monitoring of vital signs, medication administration, and basic supportive nursing interventions.
Blood Pressure
Change in systolic and diastolic blood pressure from baseline to after completion of the 3-day intervention.
Time frame: Baseline and after completion of the 3-day intervention
Pulse Rate
Change in pulse rate from baseline to after completion of the 3-day intervention.
Time frame: Baseline and after completion of the 3-day intervention
Respiratory Rate
Change in respiratory rate from baseline to after completion of the 3-day intervention
Time frame: Baseline and after completion of the 3-day intervention
Pain Degree
Change in pain score measured using the Critical-Care Pain Observation Tool (CPOT; range 0-8), where higher scores indicate more severe pain, from baseline to after completion of the 3-day intervention.
Time frame: Baseline and after completion of the 3-day intervention
Projectile Vomiting
Change in nausea and vomiting severity measured using the Rhodes Index of Nausea, Vomiting, and Retching (RINVR; range 0-32), where higher scores indicate more severe symptoms, from baseline to after completion of the 3-day intervention.
Time frame: Baseline and after completion of the 3-day intervention
Plan to share: No
Start is estimated for Mar 2026; primary completion for May 2026, 2 months later.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 2 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitas Muhammadiyah Surakarta